Boston Scientific's Latest Purchase Is a Strong Buyhttp://www.fool.com/investing/general/2012/11/09/boston-scientifics-latest-purchase-is-a-strong-buy.aspx Dan Carroll
November 9, 2012
It's been a rough go lately for Boston Scientific (NYSE: BSX ) , the medical device maker whose stock has fallen more than 9% over the last month. The company's most recent quarterly report offered up a big batch of weakness, with revenues missing expectations and declining year-over-year. Given that sort of bad news surrounding this company, you might think that now would be the absolute worst time to make a splash with an acquisition. As it turns out, Boston Scientific's latest purchase might be just what the doctor ordered.
The latest in hypertension
On Wednesday, however, Boston Scientific purchased hypertension device maker Vessix Vascular for up to $425 million. Out of that sum, $125 million will come up front, while the remaining possibility of $300 million more in milestone payments could add up through 2017.
Why's this important?